Arterial hypertension is a chronic disease that affects approximately 40% of the
population, with higher incidence at older ages.[1] Arterial hypertension is a risk factor for other cardiovascular
diseases, such as heart failure, stroke, atherosclerosis and also chronic renal disease.
It is estimated that more than 50% of deaths from coronary diseases and stroke occur in
hypertensivepatients;[2] for this
reason, hypertension produces high costs in health and constitutes a public health
problem.[3] In this context, the
development of nonpharmacological therapies is a cost-effective strategy with few side
effects, that helps in the prevention of comorbidities, such as diabetes and obesity,
and increases the cardiovascular risk of the patient. Among nonpharmacological
strategies, physical exercise deserves consideration.Rodrigues et al.,[4] in the study
published in this issue of Arquivos Brasileiros de Cardiologia,
evaluated the effect of moderate aerobic exercise on a treadmill in spontaneously
hypertensiverats. The animals ran at 18-22m/min for 60 minutes, five times a week, for
eight weeks.[4] The study confirmed the
anti-hypertensive effects of aerobic exercise, as already reported previously.[5] More recently, other types of exercise
in addition to aerobic training, such as resistance and interval training, have been
shown to be promising in preventing hypertension.[6] Prescription of physical exercise for the treatment and
prevention of hypertension is well established, and more recent guidelines for the
treatment of hypertension strongly recommend exercise as a therapeutic option.[1],[2]Even though no doubt remains about the importance of physical exercise for the management
of hypertension, the mechanisms of the beneficial effects have not been fully
elucidated. In this regard, the study by Rodrigues et al.[4] proposed to investigate the transient concentration of
intracellular calcium as well as the expression of microRNA (miRNA)-214, which is
related to regulation of intracellular calcium and Serca-2a expression. The authors
observed that physical exercise, in the presence of hypertension, increased the
amplitude and decreased decay time of cytosolic calcium, which may suggest a higher
availability of intracellular calcium, faster removal of this ion from the cytosol, and
consequently, increased cellular relaxation. These results contribute to the
understating of biological processes induced by exercises in the cardiomyocytes.Another interesting result of the study by Rodrigues et al.[4] was that non-hypertensive animals that underwent
exercise training did not have any change in miRNA-214 expression whereas hypertensive
animals that underwent training showed higher expression of this miRNA. MiRNAs are small
RNA fragments that do not encode proteins, and negatively regulate gene expression at a
post-transcriptional level. When discovered, miRNAs were believed to be non-functional
sequences; however, since the 90’s decade, the interest in these molecules has grown and
today is known to be involved in the regulation of important biological processes,
including physiological and pathological ones.[7] In hypertension, clinical and experimental studies have
identified many miRNAs that may be related to the hypertension and its
complications,[8] emerging as
possible biological markers and therapeutic targets in hypertension.[9]MiRNAs constitute a complex biological control network – one miRNA can have multiple
genes as targets, while one gene can be regulated by many miRNAs.[10] So far, all possible interactions
between miRNAs involved in a signaling pathway, as well as the regulatory mechanisms of
miRNA functions are unknown. Maybe a miRNA expression panel is a stronger determinant
than the expression of one unique miRNA in disease conditions. Despite these
uncertainties, the promising role of miRNAs for the future of medicine is
unquestionable, be it as a biomarker or as a therapeutic target.Despite the results of this study, the underlying mechanisms of the beneficial effect of
exercise still need to be elucidated.
Authors: Fernando Dimeo; Nikolaos Pagonas; Felix Seibert; Robert Arndt; Walter Zidek; Timm H Westhoff Journal: Hypertension Date: 2012-07-16 Impact factor: 10.190
Authors: Leslee J Shaw; Abhinav Goyal; Christina Mehta; Joe Xie; Lawrence Phillips; Anita Kelkar; Joseph Knapper; Daniel S Berman; Khurram Nasir; Emir Veledar; Michael J Blaha; Roger Blumenthal; James K Min; Reza Fazel; Peter W F Wilson; Matthew J Budoff Journal: J Am Coll Cardiol Date: 2018-03-13 Impact factor: 24.094
Authors: Paul K Whelton; Robert M Carey; Wilbert S Aronow; Donald E Casey; Karen J Collins; Cheryl Dennison Himmelfarb; Sondra M DePalma; Samuel Gidding; Kenneth A Jamerson; Daniel W Jones; Eric J MacLaughlin; Paul Muntner; Bruce Ovbiagele; Sidney C Smith; Crystal C Spencer; Randall S Stafford; Sandra J Taler; Randal J Thomas; Kim A Williams; Jeff D Williamson; Jackson T Wright Journal: Hypertension Date: 2017-11-13 Impact factor: 9.897
Authors: Simona Ultimo; Giorgio Zauli; Alberto M Martelli; Marco Vitale; James A McCubrey; Silvano Capitani; Luca M Neri Journal: Oncotarget Date: 2018-03-30
Authors: Giuseppe Mancia; Robert Fagard; Krzysztof Narkiewicz; Josep Redon; Alberto Zanchetti; Michael Böhm; Thierry Christiaens; Renata Cifkova; Guy De Backer; Anna Dominiczak; Maurizio Galderisi; Diederick E Grobbee; Tiny Jaarsma; Paulus Kirchhof; Sverre E Kjeldsen; Stéphane Laurent; Athanasios J Manolis; Peter M Nilsson; Luis Miguel Ruilope; Roland E Schmieder; Per Anton Sirnes; Peter Sleight; Margus Viigimaa; Bernard Waeber; Faiez Zannad; Josep Redon; Anna Dominiczak; Krzysztof Narkiewicz; Peter M Nilsson; Michel Burnier; Margus Viigimaa; Ettore Ambrosioni; Mark Caufield; Antonio Coca; Michael Hecht Olsen; Roland E Schmieder; Costas Tsioufis; Philippe van de Borne; Jose Luis Zamorano; Stephan Achenbach; Helmut Baumgartner; Jeroen J Bax; Héctor Bueno; Veronica Dean; Christi Deaton; Cetin Erol; Robert Fagard; Roberto Ferrari; David Hasdai; Arno W Hoes; Paulus Kirchhof; Juhani Knuuti; Philippe Kolh; Patrizio Lancellotti; Ales Linhart; Petros Nihoyannopoulos; Massimo F Piepoli; Piotr Ponikowski; Per Anton Sirnes; Juan Luis Tamargo; Michal Tendera; Adam Torbicki; William Wijns; Stephan Windecker; Denis L Clement; Antonio Coca; Thierry C Gillebert; Michal Tendera; Enrico Agabiti Rosei; Ettore Ambrosioni; Stefan D Anker; Johann Bauersachs; Jana Brguljan Hitij; Mark Caulfield; Marc De Buyzere; Sabina De Geest; Geneviève Anne Derumeaux; Serap Erdine; Csaba Farsang; Christian Funck-Brentano; Vjekoslav Gerc; Giuseppe Germano; Stephan Gielen; Herman Haller; Arno W Hoes; Jens Jordan; Thomas Kahan; Michel Komajda; Dragan Lovic; Heiko Mahrholdt; Michael Hecht Olsen; Jan Ostergren; Gianfranco Parati; Joep Perk; Jorge Polonia; Bogdan A Popescu; Zeljko Reiner; Lars Rydén; Yuriy Sirenko; Alice Stanton; Harry Struijker-Boudier; Costas Tsioufis; Philippe van de Borne; Charalambos Vlachopoulos; Massimo Volpe; David A Wood Journal: Eur Heart J Date: 2013-06-14 Impact factor: 29.983
Authors: Olga D Lebedeva; Abduahat A Achilov; Zilola F Mavlyanova; Alexey V Baranov; Shachnosa A Achilova; Natalia P Sanina; Anatoly D Fesyun; Andrey P Rachin; Maxim Yu Yakovlev; Kirill V Terentev; Igor V Reverchuk; Alie S Velilyaeva; Maria Chiara Maccarone; Stefano Masiero Journal: Eur J Transl Myol Date: 2021-12-15